Table 3.
Patient | ||||
---|---|---|---|---|
Authors | Population | Results | Conclusions | Comments/Findings |
Elsergany and Ghoniem, | 35 men with ISD | 20 % dry | Transurethral collagen | Procedures were performed |
199823 | (mean age 69 y) | 31 % improved | injection is a safe and | under local anesthesia |
followed for 3–22 | 49% no improvement | reasonable option | with monitored | |
mo (mean 18 mo) | Average volume used | for men with ISD. | anesthesia care. | |
for dry/improvement | ||||
cases: 8.2 mL, | History of pelvic | Abdominal leak point | ||
2 sessions | irradiation, urethral | pressure increased | ||
stricture, or involuntary | significantly after | |||
bladder contractions | injection, from 69 cm | |||
can jeopardize results. | H2O to 116 cm H2O. | |||
Complications are low. | ||||
Cummings et al, | 19 men with post- | 21 % dry | Collagen injection can | |
199624 | radical prostatec- | 37 % improved | be helpful for men | |
tomy stress incon- | 42 % no improvement | with stress incon- | ||
tinence, followed | Average volume used | tinence induced by | ||
for 3–15 mo | for dry/improved | radical prostatectomy. | ||
(mean 10 mo) | cases: 13.8 mL, | |||
1.8 sessions | Tissue scarring and | |||
preoperative severity | ||||
of leakage affect results. | ||||
Aboseif et al, 199622 | 88 men with ISD | 48 % dry | Transurethral collagen | Collagen was injected |
(men age 68 y) | 37 % improved | injection is effective | slowly, under direct | |
followed for | 15 % no improvement | and safe in carefully | supervision, on both | |
6–12 mo (mean | Average volume | selected patients | sides until coaptation | |
10 mo) | used for dry/ | with ISD. | was achieved. | |
improved cases: | ||||
22.7 mL, 3.4 | Tissue scarring and | Treatment endpoint | ||
sessions | preoperative severity | was cure of 5 | ||
of leakage affected | injections. | |||
outcomes. | ||||
Most injections were | ||||
No significant | performed under | |||
morbidity is | local anesthesia. | |||
associated with | ||||
collagen injection. |
ISD, intrinsic sphincteric deficiency.